Eureka Forbes Q1FY27: consolidated PAT +47% flattered by one-off; OPM slips to 9.9%
PAT +47.26% YoY · revenue +15.22% · margins compressing
₹700.4 Cr
+15.22% YoY
₹56.99 Cr
+47.26% YoY
8.05%
+1.8pp YoY
₹2.93
Eureka Forbes reported consolidated revenue from operations of ₹700.4 Cr for Q1 FY27 (quarter ended June 30, 2026), up 15.2% YoY from ₹607.9 Cr and up 2.4% QoQ from ₹683.7 Cr. Consolidated PAT came in at ₹57.0 Cr, up 47.3% YoY and 11.7% QoQ, with basic EPS of ₹2.93 versus ₹1.99 a year ago. No Q1FY27-specific brokerage consensus could be located — the results were only approved by the board today; the only market estimate found was Trendlyne's full-year FY27 consensus (13 analysts) of roughly 13.5% revenue growth and 44.7% PAT growth, which is a full-year figure and not a valid single-quarter benchmark, so vsStreet is marked unknown rather than inferred.
Q1 FY-2027 vs prior quarters
The PAT headline is flattered by a one-off: during the quarter the company amended its gratuity scheme to align with the Payment of Gratuity Act, 1972, and the resulting actuarial remeasurement produced a ₹19.54 Cr reversal of gratuity expense, booked as an exceptional item (identical amount in both standalone and consolidated). Stripping that out, profit before exceptional items and tax was ₹57.1 Cr, and adjusted PAT works out to roughly ₹42.5 Cr — putting underlying YoY PAT growth at approximately +9.7%, well below the reported +47.3% and also trailing the 15.2% revenue growth, meaning operating leverage worked against the company this quarter. That shows up directly in the operating margin: OPM (revenue-based operating profit margin, unaffected by the exceptional item) compressed to 9.9% from 10.1% a year ago and fell sharply from 12.5% in Q4 FY26. This runs counter to management's Q4 FY26 concall guidance to "at least hold margins in FY27 despite cost inflation" — on this quarter's print that commitment was not met, even though the volume-led revenue growth they targeted did materialise.
The stock went into the print at ₹465.6, down 0.7% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters.
What the summary numbers don't show
Reported NPM 8.05% vs 7.41% (Q4FY26) and 6.29% (Q1FY26) is largely one-off driven; adjusted NPM of ~6.0% is roughly flat YoY.
Management provided guidance indicating an expectation to step up revenue growth in FY27, with a primary focus on volume expansion rather than pricing. They aim to at least hold margins in FY27 despite cost inflation, leveraging efficiency programs and a diversified portfolio. Long-term guidance remains firm, targeting
— This quarter: missed
No management press release accompanied this filing, so there is no fresh commentary to cross-check against the numbers beyond the standard board disclosures. Alongside the results, promoter entity Lunolux Midco disclosed encumbrance of 62.55% of its stake and Catalyst Trusteeship separately disclosed a pledge of 11.4 million shares in the weeks before the results — a shareholding/governance datapoint worth flagging, though unrelated to this quarter's operating performance. Employee costs this quarter also carried a ₹6.66 Cr (₹665.96 lakh) ESOP share-based payment charge under Ind AS 102.
W1
Whether OPM recovers toward the ~12%+ level seen in Q4FY26 or stabilises near 10%, against management's commitment to at least hold margins in FY27.
W2
Whether the 15.2% YoY, volume-led revenue growth pace sustains through FY27 toward the long-term FY30 targets across water purifiers, robotics, air purifiers, water softeners and filters.
W3
Whether Q2FY27 PAT growth reverts to the ~9-10% adjusted underlying run-rate now that the ₹19.5 Cr one-off gratuity reversal will not repeat.
Both standalone and consolidated PBT/PAT carry a ₹19.54 Cr exceptional gain (reversal of gratuity expense from a scheme amendment to the Payment of Gratuity Act, 1972) — excluded in adjustedPatYoYPct. NCI ~₹0.01 Cr, immaterial. Converted from ₹ Lakh to ₹ Cr (÷100). Unaudited, subject to limited review only.
Informational and educational content only. Not investment advice.